次に

自動再生

Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma

5 ビュー • 08/09/23
シェア
埋め込む
administrator
administrator
加入者
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).

もっと見せる
0 コメント sort 並び替え
フェイスブックのコメント

次に

自動再生